Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell Transplantation is a research paper published in Transplantation and Cellular Therapy (2021). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P01 CA23766
National Cancer Institute
Grant: P30 CA008748
NCI NIH HHS
Grant: P01 CA023766
Merck
Amgen
Celgene
Novartis
Miltenyi Biotec
Bristol-Myers Squibb
GlaxoSmithKline
Kao Corporation
Sanofi
Takeda Pharmaceutical Company
Takeda Pharmaceuticals USA Inc
AbbVie
Astellas Pharma US
CareDx
Pfizer
FWCI
0.13
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals